Niagen Bioscience (NAGE) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Niagen Bioscience (NAGE) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Niagen Bioscience

· NAGE

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

233.422 M

-1.02%

General

Market Cap: $233.42M
Enterprise Value: $168.15M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 64.24%
Operating Margin: 6.67%
Net Profit Margin: 12.39%
FCF Margin: 4.40%
ROA: 15.00%
ROE: 20.50%
ROIC: 8.75%
Current Ratio: 6.50
Debt-to-Equity: 0.03
Revenue Per Employee: —

Valuation (TTM)

P/E: 14.48
PEG: —
P/S: 1.80
P/FCF: 40.99
P/B: 2.82
EV/EBITDA: 9.10

Growth

Rev 1Y: 29.95%

Income Statement (TTM)

Revenue: $129.08M
Gross Margin: 64.24%
Operating Expenses: $74.31M
Operating Income: $8.62M
Net Profit: $15.99M

Balance Sheet

Rev 1Y Fwd Est

3.64%

Rev 3Y (CAGR)

21.56%

Rev 5Y (CAGR)

16.91%

Rev 10Y (CAGR)

21.89%

EPS 1Y

81.82%

EPS 1Y Fwd Est

-27.90%

EPS 3Y (CAGR)

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $66.74M
Working Capital: $82.74M
Total Assets: $106.59M
Net Debt: -$64.41M
Total Liabilities: $24.06M
Total Equity: $82.53M

Cash Flow Statement (TTM)

Cash Flow from Operations: $5.95M
Cash Flow from Investing: $5.03M
Cash Flow from Financing: -$4.71M
Free Cash Flow: $5.67M
Capital Expenditures: $275K